UNCY – unicycive therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Unicycive Therapeutics (UNCY) had its price target lowered by Benchmark Co. from $21.00 to $15.00. They now have a "speculative buy" rating on the stock.
Unicycive Therapeutics (UNCY) had its price target lowered by Guggenheim from $46.00 to $40.00. They now have a "buy" rating on the stock.
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Unicycive Therapeutics (UNCY) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Form 8-K Unicycive Therapeutics, For: Apr 06
Form 8-K Unicycive Therapeutics, For: Mar 30
Form 10-K Unicycive Therapeutics, For: Dec 31
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.